Sable
London, GB · Founded 2023 · 15 employees on LinkedIn · 3 known investors
Sable Bio develops AI-powered tools for researchers to evaluate drug safety and accelerate the development of safe and effective medicines. The company combines engineering with biological expertise to support pharmaceutical researchers in making better decisions.
Investors · 3
Competitors · 2
by search overlap
Sab5 shared keywordsSAB BIO develops disease-modifying therapeutics for Type 1 Diabetes that target the underlying autoimmune causes rather than managing symptoms. The company's lead candidate, SAB-142, aims to preserve insulin-producing beta cell function in patients with Type 1 Diabetes.
Sana Biotechnology3 shared keywordsSana is a biotech company developing engineered cell medicines, including gene therapies for gene modification and delivery, cell replacement therapies using stem cell biology, and manufacturing solutions to improve patient access to these treatments.
Companies competing with Sable for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Sable do?
- Sable Bio develops AI-powered tools for researchers to evaluate drug safety and accelerate the development of safe and effective medicines. The company combines engineering with biological expertise to support pharmaceutical researchers in making better decisions.
- Who are Sable's investors?
- Sable's investors include Seedcamp, Episode1, MMC Ventures.
- Where is Sable headquartered?
- Sable is headquartered in London, GB.